Today: 16 July 2026
Lionsgate Stock Surges as Netflix Takeover Talk Puts LION Back in Deal Spotlight
16 June 2026
1 min read

Lionsgate Stock Surges as Netflix Takeover Talk Puts LION Back in Deal Spotlight

New York, June 16, 2026, 15:04 (EDT)

  • Lionsgate Studios shares jumped after reports that Netflix is interested in the company.
  • The move reflects takeover-premium hopes, not a confirmed deal.
  • Investors’ next catalyst is whether the reported interest becomes a formal bid.

Lionsgate Studios Corp. stock rose sharply Tuesday as investors reacted to fresh takeover speculation around the film and television studio. LION recently traded at $16.35, up $1.98, with an intraday range of $14.33 to $16.69 and volume above 11.8 million shares, according to live market data. Investor’s Business Daily reported that Semafor said Netflix is interested in buying Lionsgate and that several media companies are showing interest in the studio.

The stock rose because a potential acquisition can create a takeover premium, meaning a buyer may have to offer more than the market price to persuade shareholders to sell. That same logic can pressure the possible buyer’s stock. Netflix shares fell in the same session, with IBD noting investor concern around another large media deal after Netflix lost out on Warner Bros. Discovery to Paramount Skydance earlier this year.

The M&A angle matters because Lionsgate is now a cleaner asset after its separation from Starz. The company said last year that the studio business would trade as LION and become a standalone content company with film, television, 3 Arts Entertainment and a library of more than 20,000 film and TV titles. Lionsgate Investors In its latest quarterly report, Lionsgate posted $906.5 million in revenue, $117.5 million in operating income, $70.2 million in net income and $165.4 million in adjusted OIBDA, a non-GAAP operating-profit measure before depreciation, amortization and other adjustments. CEO Jon Feltheimer said the library had “achieved a billion dollars in trailing 12-month revenue for three quarters in a row.” Lionsgate Investors

The bull case is that Lionsgate owns scarce studio assets at a time when streamers and traditional media companies still need franchises, library content and production scale. Benchmark analyst Matthew Harrigan recently raised his target to $17 from $15 and wrote, “We maintain a BUY on Lionsgate,” citing long-term business dynamics and pipeline momentum. StreetInsider.com The bear case is that the rally is now tied heavily to deal chatter. If no formal bid appears, the stock could give back part of the move, especially since analyst target data already places the shares close to, or above, several published targets. Benzinga

The next major catalyst is any sign that Netflix or another buyer has moved from interest to a concrete proposal. If that does not happen, investors will shift back to fundamentals: fiscal 2027 film performance, television delivery timing and whether Lionsgate can convert library strength into sustained free cash flow. Based on the verified facts today, LION looks risky rather than clearly cheap after the jump. The assets are attractive, but the current price now depends more on M&A follow-through than on ordinary earnings progress alone.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • PrairieSky Royalty (TSX:PSK) Q2 Earnings, Profit Margin Top Last Year; Valuation Stays High
    July 15, 2026, 7:15 PM EDT. PrairieSky Royalty (TSX:PSK) posted Q2 2026 numbers showing revenue at CA$168.9 million and basic EPS of CA$0.41. That's up from CA$112.5 million and CA$0.24 EPS a year ago. Net income for the trailing twelve months landed at CA$241.5 million on revenue of CA$503.1 million, for a 48% net profit margin. Earnings were up 8.7% compared to 3.6% revenue growth. The stock sells at a pricey 32.4x P/E, while peers sit at 25.8x. Analysts are looking for revenue to reach CA$562.7 million and net income CA$282.3 million in 2028. Profit margin and earnings growth have been solid, but the high valuation is getting attention if operator activity loses momentum.
SL Science Holding pops at Nasdaq open, SPAC risks linger
Previous Story

SL Science Holding pops at Nasdaq open, SPAC risks linger

Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms
Next Story

Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms

Go toTop